2023 SXSW Conference Hosts Psychedelic Healthcare VC Fund Palo Santo
March 09 2023 - 10:19AM
As therapeutic applications of psychedelics gain more traction in
the mainstream consciousness, psychedelics are a major focus at
SXSW 2023, the premier annual music, film, comedy and tech festival
and conference that kicks off on Friday, March 10th in Austin,
Texas.
Palo Santo, a venture capital fund focused
on emerging psychedelic healthcare market, announced it will
participate in several SXSW Psychedelics Tracks including:
Featured Session: To Trip or Not to
Trip: Saturday, March 11, 2023 11:30 a.m. to 12:30
p.m. CT at the Austin Convention Center
in Room 16AB – Join some of the
leading researchers who will share their perspectives on the future
of psychedelic science. Those with decades of experience have
knowledge that is crucial to finding the right paths forward as
psychedelics go mainstream. The psychedelic science torch is
getting passed to the next generation, with fresh perspectives on
both ancient and future medicines. Can we take the “trip” out of
psychedelics and do we want to? Will “next gen” psychedelic
compounds have an advantage over today’s medicines? Documentarian
and researcher Hamilton Morris (Hulu’s “Hamilton’s Pharmacopeia”),
pharmacology professor and Heffter Institute founder David Nichols,
professor of pharmacology at Louisiana State University Health
Sciences Center Charles Nichols, PhD (the son of David Nichols),
Psychiatry and Neuroscience Professor Rachel Yehuda (Mt. Sinai) and
Palo Santo Cofounder Tim Schlidt explore the future of psychedelic
science.
How We Changed Our Minds About
Psychedelics: Saturday, March 11,
2023 from 4:00pm to 5:00pm CT at the Austin
Convention Center in Room
9AB – If you hopped on the psychedelic bandwagon recently,
there is a good chance that your “gateway drug” was the critically
acclaimed Netflix Series - How to Change Your Mind, based on
Michael Pollan’s book, the beautifully filmed Fantastic Fungi, or
perhaps author Julie Holland’s Good Chemistry. Join renowned
mycologist Paul Stamets, documentary filmmaker Lucy Walker (How to
Change Your Mind), psychiatrist and author Dr. Julie Holland, MD,
and Palo Santo’s Daniel Goldberg for a special discussion at the
intersection of fungi, film, books, and advocacy.
Beyond the Hype: The Business of Psychedelics
2.0: Sunday,
March 12, 2023 from 2:30 p.m. to 3:30 p.m. CT
at Austin Convention
Center in Room 8ABC –
Depending on whose advice you take, investing in psychedelics might
be the best or worst decision you’ll make. While the internet is
awash in click bait showing you the latest celebrity promoting
psychedelics, sophisticated investors are doing their homework and
discovering under-the-radar opportunities before writing checks.
Public or private market investing? Biotech/drug development or
services businesses? Psilocybin, Ketamine, or new chemical
entities? Join some of the leading founders from the private sector
and thought leaders from the space, as they share their thoughts on
where the business of psychedelics is headed, what to look out for,
and how to steer clear of the pitfalls. Palo Santo Cofounder Daniel
Goldberg will be a panelist, along with UC Berkeley Center for the
Science of Psychedelics Executive Director Imran Khan, Journey
Clinical, Inc. Cofounder Myriam Barthes and Tactogen Co-Founder and
COO Luke Pustejovsky.
Women in Psychedelics Talk Psychedelics for
Women: Sunday March 12, 2023 from 2:30pm to 3:30pm
CT at the Austin Convention Center
in Room 9AB – Women are more
likely to have PTSD than men, and women also experience depression
more often, with one in seven women suffering from postpartum
depression alone. Studies suggesting good results from just a few
doses of MDMA or psilocybin combined with therapy have led the FDA
to designate those drugs as breakthrough therapies for PTSD and
treatment-resistant depression, respectively. Is this the
beginning of a brighter future for women’s health, one where common
mental disorders, symptoms of chronic pain, and intense mood swings
are managed with mind-altering trips? Hear from four psychedelic
researchers leading the charge on research and advocacy and with
unique insights into the opportunity and challenges ahead related
to psychedelics for women’s health. Johns Hopkins Psychiatrist and
Researcher Natalie Gukaysan, New York University School Of Medicine
Psychiatrist and Researcher Xiaojue Hu and Charon Navigations
President Katherine MacLean will join Author, Psychiatrist, Palo
Santo Scientific and MAPS Advisor Julie Holland.
About Palo SantoPalo Santo is a
venture capital fund focused on emerging psychedelic medicines and
therapies poised to address the growing mental health crisis. The
fund targets a diverse range of companies offering innovative
solutions across biopharma, drug development, digital therapeutics,
healthcare services and tech-enabled solutions to address the
global mental health crisis. From cutting-edge science to
commercial application, Palo Santo’s portfolio includes 20+
companies focused on advancing the field of psychedelic medicines.
For more information, please visit https://palosanto.vc/ or
https://twitter.com/PaloSantoFund.
Media Contact:Ellen
MellodyMATTIO Communications570-209-2947palosanto@mattio.com